- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04430218
Peripheral Interfaces in Amputees for Sensorimotor Integration (iSens)
January 22, 2024 updated by: VA Office of Research and Development
The purpose of this research is to gather information on the safety and effectiveness of an implanted wireless sensory enabled highly intuitive controlled prosthetic device.
Study Overview
Detailed Description
The study involves a surgical implant of cuff electrodes on the residual nerves in the amputated limb, and muscle recording electrodes in muscles.
These will be connected to an implanted stimulator.
The stimulator will connect wirelessly to an advanced prosthesis.
This may allow the user to move the prosthetic hand intuitively and feel what the prosthesis is touching.
Study Type
Interventional
Enrollment (Estimated)
15
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Dustin J Tyler, PhD
- Phone Number: (216) 791-3800
- Email: dustin.tyler@va.gov
Study Contact Backup
- Name: Melissa S Schmitt
- Phone Number: 63801 (216) 791-3800
- Email: Melissa.Schmitt@va.gov
Study Locations
-
-
Ohio
-
Cleveland, Ohio, United States, 44106-1702
- Recruiting
- Louis Stokes VA Medical Center, Cleveland, OH
-
Principal Investigator:
- Dustin J. Tyler, PhD
-
Contact:
- Holly B Henry
- Phone Number: 64657 216-791-3800
- Email: holly.henry@va.gov
-
Contact:
- Neal S Peachey, PhD
- Phone Number: (216) 421-3221
- Email: neal.peachey@va.gov
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
21 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Age 21 or greater
- Acquired upper limb amputation
- Unilateral or bilateral amputation, Above or below elbow
- At least 6 months since time of amputation
- Current user of a myoelectric prosthesis or prescribed to use one
- Viable target nerves in the upper extremity *
- Recommendation from a psychologist following a psychological assessment that the subject is mentally competent and capable of completing the study related activities
Exclusion Criteria:
- A contraindication preventing surgery
- Uncontrolled diabetes
- Chronic skin ulcerations
- History of poor wound healing without specific cause
- History of uncontrolled infection without specific cause
- Active infection
- Pregnancy or women of childbearing potential unwilling to prevent pregnancy during participation in the study
- Inability to speak English
- Expectation that MRI will be required at any point for duration of study or while device is implanted.
- Arthritis in the area of implant
- Individuals with active implantable medical devices or individuals that use external active medical devices that are medically necessary and/or life-supporting or life-sustaining (e.g. insulin pumps, ventilators)
- Presence of auto immune diseases, or conditions requiring immunosuppression.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: iSens
3 months trial with the iSens system
|
The study involves a surgical implant of cuff electrodes on the nerves in the amputated limb, and muscle recording electrodes the remaining muscles.
These will be connected to an implanted stimulator.
The stimulator will connect wirelessly to an advanced prosthesis.
This may allow a user to move the prosthetic hand intuitively and feel what your prosthesis is touching.
|
No Intervention: State of the Art Prosthesis
3 months trial with their own prosthesis.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Patient Experience Measure
Time Frame: 9 months post implant
|
Consists of 49 items and consists of five subscales, measuring Self-efficacy, Embodiment, Body image, Prosthesis Efficiency, and Social Touch.
Each scale is scored individually, and a higher score indicates a better outcome.
|
9 months post implant
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Modified Box and Blocks
Time Frame: 9 months post implant
|
Measuring the change in numbers of blocks moved during a timed test.
|
9 months post implant
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Dustin J. Tyler, PhD, Louis Stokes VA Medical Center, Cleveland, OH
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 18, 2020
Primary Completion (Estimated)
June 30, 2024
Study Completion (Estimated)
June 30, 2032
Study Registration Dates
First Submitted
May 12, 2020
First Submitted That Met QC Criteria
June 11, 2020
First Posted (Actual)
June 12, 2020
Study Record Updates
Last Update Posted (Actual)
January 23, 2024
Last Update Submitted That Met QC Criteria
January 22, 2024
Last Verified
January 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- A3355-R
- RX003355-01 (Other Grant/Funding Number: VA RR&D)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
Deidentified data will be uploaded to a data repository.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Upper Extremity Amputee
-
University of Texas at AustinCompletedUpper Extremity Dysfunction | Lower Extremity ProblemUnited States
-
Christina L. Kaufman PhDUnited States Department of Defense; U.S. Army Medical Research and Development... and other collaboratorsUnknownUpper Extremity InjuriesUnited States
-
Hôpital du ValaisUniversity of Lausanne HospitalsCompleted
-
Hacettepe UniversityCompletedUpper Extremity InjuriesTurkey
-
Postgraduate Institute of Medical Education and...CompletedUpper Extremity Injury Trauma
-
Beijing Jishuitan HospitalCompletedUpper ExtremityChina
-
Beijing Jishuitan HospitalCompletedUpper Extremity Injury TraumaChina
-
Riphah International UniversityNot yet recruitingUpper Extremity ProblemPakistan
-
Chinese University of Hong KongCompleted
-
University of Texas Southwestern Medical CenterCompletedUpper Extremity SurgeryUnited States
Clinical Trials on iSens
-
Kangbuk Samsung HospitalDaewoong Pharmaceutical Co. LTD.RecruitingGestational Diabetes Mellitus in PregnancyKorea, Republic of
-
Foundation for Innovative New Diagnostics, SwitzerlandRecruiting